BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: El Jabbour T, Lagana SM, Lee H. Update on hepatocellular carcinoma: Pathologists’ review. World J Gastroenterol 2019; 25(14): 1653-1665 [PMID: 31011252 DOI: 10.3748/wjg.v25.i14.1653]
URL: https://www.wjgnet.com/1948-5182/full/v25/i14/1653.htm
Number Citing Articles
1
Emine Turkmen Samdanci. Hepatocellular Carcinoma - Challenges and Opportunities of a Multidisciplinary Approach2022;  doi: 10.5772/intechopen.99842
2
Qing-fang Wang, Qing-lin Wang, Ming-bo Cao. LncRNA PITPNA-AS1 as a Potential Diagnostic Marker and Therapeutic Target Promotes Hepatocellular Carcinoma Progression via Modulating miR-448/ROCK1 AxisFrontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.668787
3
Nese Karadag Soylu. Update on Hepatocellular Carcinoma: a Brief Review from Pathologist StandpointJournal of Gastrointestinal Cancer 2020; 51(4): 1176 doi: 10.1007/s12029-020-00499-5
4
Eric Lachance, Jake Mandziuk, Consolato M. Sergi, Justin Bateman, Gavin Low. Liver Cancer2021; : 87 doi: 10.36255/exonpublications.livercancer.2021.ch5
5
Soo-Jin Cho. Pediatric Liver TumorsSurgical Pathology Clinics 2020; 13(4): 601 doi: 10.1016/j.path.2020.09.002
6
Soumya Jogi, Radha Varanai, Sravani S. Bantu, Ashish Manne. Selecting the first line treatment in non-metastatic hepatocellular carcinoma - comparing clinical practice guidelinesOncology Reviews 2020; 14(2) doi: 10.4081/oncol.2020.515
7
Pattamon Sutthatarn, Cara E. Morin, Jessica Gartrell, Wayne L. Furman, Max R. Langham, Teresa Santiago, Andrew J. Murphy. Bilateral Diffuse Nodular Pulmonary Ossification Mimicking Metastatic Disease in a Patient with Fibrolamellar Hepatocellular CarcinomaChildren 2021; 8(3): 226 doi: 10.3390/children8030226
8
Thais Maloberti, Antonio De Leo, Viviana Sanza, Elisa Gruppioni, Annalisa Altimari, Mattia Riefolo, Michela Visani, Deborah Malvi, Antonia D’Errico, Giovanni Tallini, Francesco Vasuri, Dario de Biase. Correlation of molecular alterations with pathological features in hepatocellular carcinoma: Literature review and experience of an Italian centerWorld Journal of Gastroenterology 2022; 28(25): 2854-2866 doi: 10.3748/wjg.v28.i25.2854
9
Ioannis A. Ziogas, Laura A. Hickman, Lea K. Matsuoka, Manhal Izzy, Martin I. Montenovo, Scott A. Rega, Irene D. Feurer, Sophoclis P. Alexopoulos. Comparison of Wait‐List Mortality Between Cholangiocarcinoma and Hepatocellular Carcinoma Liver Transplant CandidatesLiver Transplantation 2020; 26(9): 1112 doi: 10.1002/lt.25807
10
Hua Ren, Zhi-cheng Wei, Yan-xia Sun, Chun-yan Qiu, Wen-jue Zhang, Wei Zhang, Tao Liu, Xu Che. ATF2-Induced Overexpression of lncRNA LINC00882, as a Novel Therapeutic Target, Accelerates Hepatocellular Carcinoma Progression via Sponging miR-214-3p to Upregulate CENPMFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.714264
11
Yu Huang, Wenhao Ge, Yuan Ding, Lufei Zhang, Jiarong Zhou, Yang Kong, Bijun Cui, Bingqiang Gao, Xiaohui Qian, Weilin Wang. The circular RNA circSLC7A11 functions as a mir-330-3p sponge to accelerate hepatocellular carcinoma progression by regulating cyclin-dependent kinase 1 expressionCancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02351-7
12
Akihiro Nakayama, Jun Arai, Yumi Otoyama, Ikuya Sugiura, Yoko Nakajima, Atsushi Kajiwara, Yuki Ichikawa, Shojiro Uozumi, Yuu Shimozuma, Manabu Uchikoshi, Masashi Sakaki, Sakiko Tazawa, Eisuke Shiozawa, Toshiko Yamochi, Masafumi Takimoto, Hitoshi Yoshida. Muscular Metastasis of Hepatocellular Carcinoma: Case Report and Literature ReviewInternal Medicine 2022; 61(2): 189 doi: 10.2169/internalmedicine.7200-21
13
Yunpeng Kong, Yan Jing, Hongmei Sun, Shisheng Zhou, Bhagyaveni M.A. The Diagnostic Value of Contrast-Enhanced Ultrasound and Enhanced CT Combined with Tumor Markers AFP and CA199 in Liver CancerJournal of Healthcare Engineering 2022; 2022: 1 doi: 10.1155/2022/5074571
14
Feng Xia, Qiao Zhang, Zhiyuan Huang, Elijah Ndhlovu, Mingyu Zhang, Xiaoping Chen, Bixiang Zhang, Peng Zhu. Effect of Perioperative Blood Transfusion on the Postoperative Prognosis of Ruptured Hepatocellular Carcinoma Patients With Different BCLC Stages: A Propensity Score Matching AnalysisFrontiers in Surgery 2022; 9 doi: 10.3389/fsurg.2022.863790
15
Rama Rao Malla, Rakshmitha Marni, Anandita Chakraborty. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 22022; : 321 doi: 10.1016/B978-0-323-98807-0.00004-1
16
Wanjing Zheng, Hongjie Huang, Dejun She, Meilian Xiong, Xiaodan Chen, Xiaojun Lin, Dairong Cao. Added-value of ancillary imaging features for differentiating hepatocellular carcinoma from intrahepatic mass-forming cholangiocarcinoma on Gd-BOPTA-enhanced MRI in LI-RADS MAbdominal Radiology 2022; 47(3): 957 doi: 10.1007/s00261-021-03380-6
17
Anil Aysal, Betul Gundogdu, Burcin Pehlivanoglu, Sumeyye Ekmekci, M. Hasan Toper, Canan Kelten Talu, Ibrahim H. Erdogdu, Duygu Gurel, Merih Guray Durak, Emine Cagnur Ulukus, Sermin Ozkal, Burcin Tuna, Ozgul Sagol, Sulen Sarioglu, Alena Skálová. Biomarkers in Carcinoma of Unknown Primary2022; : 335 doi: 10.1007/978-3-030-84432-5_12
18
Anastasia Lemekhova, Daniel Hornuss, Georgios Polychronidis, Philipp Mayer, Christian Rupp, Thomas Longerich, Karl-Heinz Weiss, Markus Büchler, Arianeb Mehrabi, Katrin Hoffmann. Clinical features and surgical outcomes of fibrolamellar hepatocellular carcinoma: retrospective analysis of a single-center experienceWorld Journal of Surgical Oncology 2020; 18(1) doi: 10.1186/s12957-020-01855-2
19
Meenakshi Gupta, Jamal Akhtar, Maryam Sarwat. MicroRNAs: Regulators of immunological reactions in hepatocellular carcinomaSeminars in Cell & Developmental Biology 2022; 124: 127 doi: 10.1016/j.semcdb.2021.05.025
20
Anil Aysal, Ozgul Sagol. Biomarkers in Carcinoma of Unknown Primary2022; : 201 doi: 10.1007/978-3-030-84432-5_8
21
Mukul Vij, Julien Calderaro. Pathologic and molecular features of hepatocellular carcinoma: An updateWorld Journal of Hepatology 2021; 13(4): 393-410 doi: 10.4254/wjh.v13.i4.393
22
Mihajlo Djokic, Maja Cemazar, Masa Bosnjak, Rok Dezman, David Badovinac, Damijan Miklavcic, Bor Kos, Miha Stabuc, Borut Stabuc, Rado Jansa, Peter Popovic, Lojze M. Smid, Gregor Sersa, Blaz Trotovsek. A Prospective Phase II Study Evaluating Intraoperative Electrochemotherapy of Hepatocellular CarcinomaCancers 2020; 12(12): 3778 doi: 10.3390/cancers12123778
23
Marianne Ziol. Histoséminaire de la société française de pathologie Histoséminaire « Pathologie tumorale hépatique ». Cas n°7Annales de Pathologie 2021; 41(5): 449 doi: 10.1016/j.annpat.2021.02.009
24
Lorenza Rimassa, Nicola Personeni, Carolin Czauderna, Friedrich Foerster, Peter Galle. Systemic treatment of HCC in special populationsJournal of Hepatology 2021; 74(4): 931 doi: 10.1016/j.jhep.2020.11.026
25
Michel Kmeid, Georgi Lukose, Kyle Hodge, Daniel Cho, Kelly‐Ann Kim, Hwajeong Lee. Aberrant expression of SATB2, CDX2, CDH17 and CK20 in hepatocellular carcinoma: a pathological, clinical and outcome studyHistopathology 2021; 79(5): 768 doi: 10.1111/his.14420
26
Xun Wang, Fang‐yuan Li, Wei Zhao, Zhi‐kang Gao, Bin Shen, Hao Xu, Yan‐feng Cui. Long non‐coding RNA GAS5 overexpression inhibits M2‐like polarization of tumour‐associated macrophages in SMCC‐7721 cells by promoting PTEN expressionInternational Journal of Experimental Pathology 2020; 101(6): 215 doi: 10.1111/iep.12374
27
Yating Xu, Xiao Yu, Zongzong Sun, Yuting He, Wenzhi Guo. Roles of lncRNAs Mediating Wnt/β-Catenin Signaling in HCCFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.831366
28
Xiaoyuan Chen, Yiwei Lu, Xiaoli Shi, Guoyong Han, Long Zhang, Chuangye Ni, Jie Zhao, Yun Gao, Xuehao Wang. Epidemiological and Clinical Characteristics of Five Rare Pathological Subtypes of Hepatocellular CarcinomaFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.864106
29
Xia Chen, Ling Liao, Yuwei Li, Hengliu Huang, Qing Huang, Shaoli Deng. Screening and Functional Prediction of Key Candidate Genes in Hepatitis B Virus-Associated Hepatocellular CarcinomaBioMed Research International 2020; 2020: 1 doi: 10.1155/2020/7653506
30
Xue‐Song Zheng, Hai‐Jie Liu, Lian‐Lian Zhang, Hui Li, Chun‐Jing Wang, Ye‐Jiu Xin, Rui Hao. MiR ‐559 targets GP73 to suppress proliferation and invasion of hepatocellular carcinoma in vitro The Kaohsiung Journal of Medical Sciences 2020; 36(10): 793 doi: 10.1002/kjm2.12246
31
John S. Lubel, Stuart K. Roberts, Jessica Howell, James Ward, Nichols A. Shackel. Current issues in the prevalence, diagnosis and management of hepatocellular carcinoma in AustraliaInternal Medicine Journal 2021; 51(2): 181 doi: 10.1111/imj.15184
32
Qiheng Gou, Shengya Fu, Yuxin Xie, Mengni Zhang, Yali Shen. Treatment and Survival Patterns of Primary Adenosquamous Carcinoma of the Liver: A Retrospective AnalysisFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.621594
33
Yun Li, Hui Xiong. Correlation of LAGE3 with unfavorable prognosis and promoting tumor development in HCC via PI3K/AKT/mTOR and Ras/RAF/MAPK pathwaysBMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09398-3
34
Chih‐Chieh Yen, Chia‐Jui Yen, Yan‐Shen Shan, Yih‐Jyh Lin, I‐Ting Liu, Hsuan‐Yi Huang, Matthew M Yeh, Shih‐Huang Chan, Hung‐Wen Tsai. Comparing the clinicopathological characteristics of combined hepatocellular–cholangiocarcinoma with those of other primary liver cancers by use of the updated World Health Organization classificationHistopathology 2021; 79(4): 556 doi: 10.1111/his.14384
35
Chun Li, Xin-You Pan, Mingyun Ma, Jun Zhao, Fengda Zhao, Ya-Ping Lv. Astragalus polysacharin inhibits hepatocellular carcinoma-like phenotypes in a murine HCC model through repression of M2 polarization of tumour-associated macrophagesPharmaceutical Biology 2021; 59(1): 1531 doi: 10.1080/13880209.2021.1991384
36
Yongjia Tang, Haoran Xu, Yaxue Dai, Fang Wang, Wenjing Huang, Peifei Liu, Yueqing Gu. A novel peptide targeting c-Met for hepatocellular carcinoma diagnosisJournal of Materials Chemistry B 2021; 9(22): 4577 doi: 10.1039/D1TB00408E
37
Charissa Kim, Natasha Cigarroa, Venkateswar Surabhi, Balaji Ganeshan, Anil K. Pillai. Retrospective CT/MRI Texture Analysis of Rapidly Progressive Hepatocellular CarcinomaJournal of Personalized Medicine 2020; 10(3): 136 doi: 10.3390/jpm10030136
38
Paula Piedade GARCIA, Ronniel Morais ALBUQUERQUE, Fernanda Maria Farage OSÓRIO, Cláudia Alves COUTO, Agnaldo Soares LIMA, Paula Vieira Teixeira VIDIGAL. B-RAF PROTEIN IMMUNOEXPRESSION IN HEPATOCELLULAR CARCINOMA DUE TO HEPATITIS C VIRUS RELATED CIRRHOSISArquivos de Gastroenterologia 2021; 58(4): 419 doi: 10.1590/s0004-2803.202100000-76
39
Li Zhao, Qian Yang, Jianbo Liu. Clinical Value Evaluation of microRNA-324-3p and Other Available Biomarkers in Patients With HBV Infection–Related Hepatocellular CarcinomaOpen Forum Infectious Diseases 2021; 8(6) doi: 10.1093/ofid/ofab108
40
Xuping Wu, Qi Wang, Yousheng Lu, Jinye Zhang, Hanwei Yin, Yongxiang Yi. Clinical application of thioredoxin reductase as a novel biomarker in liver cancerScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-85688-3
41
Hailan Bao, Qi Muge. Anticancer effect of myristicin on hepatic carcinoma and related molecular mechanismPharmaceutical Biology 2021; 59(1): 1124 doi: 10.1080/13880209.2021.1961825
42
Abdul Razik, Sundeep Malla, Ankur Goyal, Shivanand Gamanagatti, Devasenathipathy Kandasamy, Chandan Jyoti Das, Raju Sharma, Arun Kumar Gupta. Unusual Primary Neoplasms of the Adult Liver: Review of Imaging Appearances and Differential DiagnosisCurrent Problems in Diagnostic Radiology 2022; 51(1): 73 doi: 10.1067/j.cpradiol.2020.10.001
43
Aurélie Beaufrère, Julien Calderaro, Valérie Paradis. Combined hepatocellular-cholangiocarcinoma: An updateJournal of Hepatology 2021; 74(5): 1212 doi: 10.1016/j.jhep.2021.01.035
44
Dongwei Zhang, Tanzy Love, Yansheng Hao, Bella Lingjia Liu, Swan Thung, Maria Isabel Fiel, Christa L Whitney-Miller, Xiaoyan Liao. Tumor Size, Not Small Vessel Invasion, Predicts Survival in Patients With Hepatocellular CarcinomaAmerican Journal of Clinical Pathology 2022; 158(1): 70 doi: 10.1093/ajcp/aqac001
45
Yohan Kim, Young Seok Kim, Jeong-Ju Yoo, Sang Gyune Kim, Susie Chin, Ahrim Moon. Rare case of hepatocellular carcinoma metastasis to urinary bladder: A case report World Journal of Clinical Cases 2022; 10(16): 5470-5478 doi: 10.12998/wjcc.v10.i16.5470
46
Natalia Pediconi, Debora Salerno, Leonardo Lupacchini, Annapaola Angrisani, Giovanna Peruzzi, Enrico De Smaele, Massimo Levrero, Laura Belloni. EZH2, JMJD3, and UTX epigenetically regulate hepatic plasticity inducing retro-differentiation and proliferation of liver cellsCell Death & Disease 2019; 10(7) doi: 10.1038/s41419-019-1755-2
47
Bufu Tang, Jinyu Zhu, Jie Li, Kai Fan, Yang Gao, Shimiao Cheng, Chunli Kong, Liyun Zheng, Fazong Wu, Qiaoyou Weng, Chenying Lu, Jiansong Ji. The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinomaCell Communication and Signaling 2020; 18(1) doi: 10.1186/s12964-020-00663-1
48
Suchira Gallage, María García-Beccaria, Marta Szydlowska, Mohammad Rahbari, Raphael Mohr, Frank Tacke, Mathias Heikenwalder. The therapeutic landscape of hepatocellular carcinomaMed 2021; 2(5): 505 doi: 10.1016/j.medj.2021.03.002
49
Hernan R. Bello, Zaid K. Mahdi, Shu K. Lui, Sadhna B. Nandwana, Peter A. Harri, Amir H. Davarpanah. Hepatocellular Carcinoma With Atypical Imaging Features: Review of the Morphologic Hepatocellular Carcinoma Subtypes With Radiology‐Pathology Correlation Journal of Magnetic Resonance Imaging 2022; 55(3): 681 doi: 10.1002/jmri.27553
50
Yuting Hu, Wei Qiu, Zhijun Kong, Siyuan Wu, Yi Liu, Chunfu Zhu, Xihu Qin, Aaron Bell. LncRNA GSTM3TV2 Promotes Cell Proliferation and Invasion via miR-597/FOSL2 Axis in Hepatocellular CarcinomaBioMed Research International 2021; 2021: 1 doi: 10.1155/2021/3445970